Myb News · Oct 29, 2026
Myb News — photo status
*Eli Lilly expects full-year sales to hit as much as $92 billion* The pharmaceutical company reported third-quarter revenue that blew past estimates. Demand for Mounjaro and Zepbound drove the surge, with Mounjaro revenue rising 65 percent to $10.72 billion. Eli Lilly now expects full-year sales between $91 billion and $92 billion. *For the full story* https://mybnews.com/a/eli-lilly-beats-estimates-and-hikes-2026-sales-to-92-billion
More from Myb News
- Myb NewsNov 4, 2026 · Valuetainment’s Patrick Bet-David proposed that anyone under
- Myb NewsNov 4, 2026 · Con Edison stock hits $116 after a 77 percent gain Consolida

- Myb NewsNov 4, 2026 · SpaceX and Qualcomm are building a dual-network that uses ci

- Myb NewsNov 4, 2026 · Israel's biggest food company aims for a valuation over NIS

- Myb NewsNov 4, 2026 · Wayfair is grabbing more market share despite a slow housing

- Myb NewsNov 4, 2026 · CVS is splitting into two separate companies by early 2028 T
